Clinical Trial Update: Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on continuous soluble ferric pyrophosphate delivered via dialysate for iron delivery in hemodialysis patients; study completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Ferric pyrophosphate citrate (soluble ferric pyrophosphate, SFP) (ferric pyrophosphate citrate)

Snippet

Sponsor: Rockwell Medical Technologies, Inc. | Conditions: End Stage Renal Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-03-26